161 related articles for article (PubMed ID: 31736606)
1. Tryptophan catabolism in epithelial ovarian carcinoma.
Smith LP; Bitler BG; Richer JK; Christenson JL
Trends Cancer Res; 2019; 14():1-9. PubMed ID: 31736606
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
Sari S; Tomek P; Leung E; Reynisson J
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2.
Tijono SM; Palmer BD; Tomek P; Flanagan JU; Henare K; Gamage S; Braun L; Ching LM
Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145311
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of L- and D-5-[
Tang T; Gill HS; Ogasawara A; Tinianow JN; Vanderbilt AN; Williams SP; Hatzivassiliou G; White S; Sandoval W; DeMent K; Wong M; Marik J
Nucl Med Biol; 2017 Aug; 51():10-17. PubMed ID: 28511073
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma.
Zhang S; Gao Y; Wang P; Wang S; Wang Y; Li M; Wang A; Zhao K; Zhang Z; Sun J; Guo D; Liang Z
Cancer Med; 2023 Dec; 12(24):21996-22005. PubMed ID: 38062922
[TBL] [Abstract][Full Text] [Related]
6. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function.
Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH
Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.
Puccetti P; Fallarino F; Italiano A; Soubeyran I; MacGrogan G; Debled M; Velasco V; Bodet D; Eimer S; Veldhoen M; Prendergast GC; Platten M; Bessede A; Guillemin GJ
PLoS One; 2015; 10(4):e0122046. PubMed ID: 25881064
[TBL] [Abstract][Full Text] [Related]
8. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
9.
Liu Q; Zhai J; Kong X; Wang X; Wang Z; Fang Y; Wang J
Mol Ther Oncolytics; 2020 Jun; 17():153-168. PubMed ID: 32346606
[TBL] [Abstract][Full Text] [Related]
10. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
11. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Löb S; Königsrainer A; Zieker D; Brücher BL; Rammensee HG; Opelz G; Terness P
Cancer Immunol Immunother; 2009 Jan; 58(1):153-7. PubMed ID: 18418598
[TBL] [Abstract][Full Text] [Related]
12. Heme-containing enzymes and inhibitors for tryptophan metabolism.
Yan D; Lin YW; Tan X
Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
[TBL] [Abstract][Full Text] [Related]
13. Targeting tryptophan availability to tumors: the answer to immune escape?
Badawy AA
Immunol Cell Biol; 2018 Nov; 96(10):1026-1034. PubMed ID: 29888434
[TBL] [Abstract][Full Text] [Related]
14. The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity.
Mbongue JC; Nicholas DA; Torrez TW; Kim NS; Firek AF; Langridge WH
Vaccines (Basel); 2015 Sep; 3(3):703-29. PubMed ID: 26378585
[TBL] [Abstract][Full Text] [Related]
15. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan Catabolism and Response to Therapy in Locally Advanced Rectal Cancer (LARC) Patients.
Crotti S; Fraccaro A; Bedin C; Bertazzo A; Di Marco V; Pucciarelli S; Agostini M
Front Oncol; 2020; 10():583228. PubMed ID: 33178611
[TBL] [Abstract][Full Text] [Related]
17. Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer.
de Jong RA; Nijman HW; Boezen HM; Volmer M; Ten Hoor KA; Krijnen J; van der Zee AG; Hollema H; Kema IP
Int J Gynecol Cancer; 2011 Oct; 21(7):1320-7. PubMed ID: 21720257
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan-catabolizing enzymes - party of three.
Ball HJ; Jusof FF; Bakmiwewa SM; Hunt NH; Yuasa HJ
Front Immunol; 2014; 5():485. PubMed ID: 25346733
[TBL] [Abstract][Full Text] [Related]
19. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.
Szántó S; Koreny T; Mikecz K; Glant TT; Szekanecz Z; Varga J
Arthritis Res Ther; 2007; 9(3):R50. PubMed ID: 17511858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
